Skip to main content

Table 2 Demographic characteristics, severity and actions taken for episodes of acute fever in the two weeks preceding the survey according to socio-economic status and geographic location

From: Treatment of Febrile illness with artemisinin combination therapy: prevalence and predictors in five African household surveys

Individuals with recent acute fever (N)

Poor

Non-Poor

 

Outside Capital

Within Capital

 
 

652

1384

 

1671

329

 
 

Proportion Estimates(95% Confindence Intervals)

Pearson chi2

Proportion Estimates(95% Confindence Intervals)

Pearson chi2

Country

  

p<0.001

  

p<0.001

Gambia

8.2(5.1,13.2)

20.2(12.8,30.4)

 

6.8(4.3,10.8)

25.9

 

Ghana

9.0(5.1,15.3)

14.7(10.0,21.0)

 

15.2(10.1,22.3)

5.6(1.8,16.2)

 

Kenya

33.9(23.5,46.1)

18.3(12.3,26.4)

 

29.2(20.7,39.5)

4.3(1.6,11.3)

 

Negeria

16.4(9.7,26.4)

20..4(14.2,28.4)

 

21.2(14.5,29.8)

12.7(5.0,28.9)

 

Uganda

32.5(22.1,44.9)

26.4(18.3,36.1)

 

27.6(19.3,37.9)

30.5(13.7, 54.9)

 

Female

52.7(48.3,57.2)

55.9(52.3,59.3)

ns

54.1(51.2,57.0)

57.4(50.0,64.4)

ns

Age umder

44.4(38.8,50.1)

36.5(33.2,40.0)

ns

40.3(36.7,44.1)

34.7(229.9,39.9)

ns

Very severe fever

19.6(15.8,24.1)

19.6(17.1,22.4)

ns

21.8(19.1,24.9)

12.6(9.5,16.4)

p<0.001

Reported associated symptoms

  

ns

  

ns

Upper respiratory (cough, runny nose, sore throat, earache)

33.5(27.9,39.6)

36.0(31.4,40.8)

ns

36.8(32.4,41.4)

30.1(22.7,38.7)

ns

Difficulty breathing, fast breathing

7.1(5.1,9.8)

6.0(4.5,7.9)

ns

7.1(5.6,9.1)

3.8(2.0,7.3)

ns

Gastro-interstinal (diarrhea, nausea, could not eat)

25.1(20.8,29.9)

22.8(19.0,27.0)

ns

23.5(20.5,26.8)

23.5(15.1,34.7)

ns

All other symptoms

35.9(28.44.2)

42.2(37.2,47.3)

ns

38.7(33.0,44.8)

44.8(35.5,54.4)

ns

Actions taken

      

Sought care outside home

88.3(84.4,91.4)

93.4(91.8,94.8)

p<0.005

91.1(88.8,92.9)

94.3(91.6,96.1)

ns

traveled more than one hour to recieve care

23.3(16.6,31.6)

13.1(10.6,15.9)

p<0.001

17.4(13.7,22.0)

12.5(8.3,18.5)

ns

received in a public health facility

52.1(46.1,58.0)

50.8(46.1,55.4)

ns

53.6(49.2,57.9)

43.6(33.7,54.0)

p<0.05

Treatment

      

Received medicines

95.3(92.6,97.0)

96.4(94.8,97.5)

ns

96.6(95.3,97.5)

94.4(89.5,97.0)

ns

obtained all medicines free-of-charge

31.2(25.4,37.7)

30.6(26.1,35.6)

ns

32.8(27.7,38.8)

24.4(17.7,32.6)

ns

Received antimalarials

64.2(59.1,68.9)

68.3(64.9,71.5)

ns

67.5(63.9,70.9)

65.4(59.6,70.8)

ns

obtained antimalarials and other medicines in public facility

36.7(31.1,42.7)

33.5(29.8,37.4)

ns

36.7(40.9)

27.5(20.2,36.2)

ns

received ACT

18.5(13.9,24.2)

15.2(12.2,18.7)

ns

18.5(15.2,22.4)

9.0(4.7,16.7)

p<0.05

obtained ACT and other medicines in public in facility

13.5(9.8,18.5)

10.6(8.3,13.5)

ns

14.4(11.5,17.8)

2.7(1.1,6.2)

p<0.0001

obtained all medicines including ACT free-of-charge

10.3(7.0,15.0)

6.9(5.0,9.4)

ns

9.9(7.4,13.1)

1.7(0.6,4.5)

p<0.001

Received antibiotics

31.3(26.9,36.0)

31.4(27.5,35.6)

ns

34.8(31.2,38.5)

20.7(14.28.5)

p<0.005

Received analgesics or NSAIDs

65.2(59.9,70.2)

70.6(67.3,73.8)

p<0.05

69.3(66.2,72.3)

67.6(58.7,75.4)

ns